evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura.

نویسندگان

mohammad saeid rahiminejad department of pediatrics, pediatrics center of excellence, children's medical center, tehran university of medical sciences, tehran, iran

mehrdad mirmohammad sadeghi department of pediatrics, pediatrics center of excellence, children's medical center, tehran university of medical sciences, tehran, iran

payam mohammadinejad research center for immunodeficiencies, tehran university of medical sciences, tehran, iran

bamdad sadeghi research center for immunodeficiencies, tehran university of medical sciences, tehran, iran

چکیده

coincidence of autoimmune diseases such as immune thrombocytopenic purpura (itp) with  immunodeficiencies has  been  reported  previously in  patients  who  suffered  from primary antibody deficiency (pad). but there is no original study on immunological profiles of itp patients to find out their probable immune deficiency. in this case-control study, itp patients’ humoral immunity was investigated for diagnosis of pad in comparison with normal population. to evaluate the humoral immune system against polysaccharide antigens, patients’ serum immunoglobulin levels were measured and a 23-valent pneumococcal  capsular polysaccharide vaccine (ppv23) was administrated  to evaluate the antibody response to vaccination. in  this  study, 14 out  of  36 patients  (39%) were diagnosed with antibody mediated immune deficiency including 2 patients (5.5%) with immunoglobulin class deficiency and 4 (11%) with igg subclass deficiency. the remaining patients suffered from specific antibody deficiency. the most frequent deficiency in itp patients was specific antibody deficiency. therefore, immunological survey on itp patients may be important especially for those who have undergone splenectomy.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura.

Coincidence of autoimmune diseases such as immune thrombocytopenic purpura (ITP) with immunodeficiencies has been reported previously in patients who suffered from primary antibody deficiency (PAD). But there is no original study on immunological profiles of ITP patients to find out their probable immune deficiency. In this case-control study, ITP patients' humoral immunity was investigated for...

متن کامل

Clinical Variables among Adult Patients with Chronic Idiopathic Thrombocytopenic Purpura in West Iran

Background: There are two forms of ITP: acute and chronic. The chronic form is defined by persistent thrombocytopenia for more than 12 months and mostly occurs among young women. The aim of the present study was to evaluate the clinical variables in adult patients with chronic ITP in West Iran. Patients and Methods: Between of 2007 and 2014, ninety adult patients with chronic ITP referred to...

متن کامل

Epidemiology of Idiopathic Thrombocytopenic Purpura in Children

Abstract Background Immune thrombocytopenic purpura (ITP) is a common autoimmune bleeding condition in children that is characterized by a decrease in the platelet count. The aims of this study were to define epidemiologic features of patients with primary ITP who were admitted to Mofid Children's Hospital, Tehran, Iran, in a 5-year period. Methods We retrospectively studied the records of ...

متن کامل

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

PURPOSE On August 22, 2008, Romiplostim (Nplate for Injection) received approval from the US Food and Drug Administration (FDA) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. This report summarizes the FDA analyses of the clinical data sup...

متن کامل

Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

PURPOSE On November 20, 2008, eltrombopag (Promacta) received approval from the US Food and Drug Administration (FDA) for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. This report summarizes the FDA analyses of the clinical data supporting this approval. ...

متن کامل

Acute Immune Thrombocytopenic Purpura in Infants

Abstract Objective Immune thrombocytopenic purpura (ITP) manifests as an easy bruising or extravasation of blood from capillaries into skin and mucous membranes. The characteristics of acute ITP in infants have rarely been described. In order to better understand acute ITP in infants, the characteristics of the disease at this age group was investigated. Material and Methods The present des...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of allergy, asthma and immunology

جلد ۱۲، شماره ۱، صفحات ۵۰-۵۶

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023